Two new potential deals have emerged today – the small tree genetics company Arborgen, and the New Zealand investment and advisory operations of Australia’s AMP.
Follow Our Network On LinkedIn: Follow link
Two new potential deals have emerged today – the small tree genetics company Arborgen, and the New Zealand investment and advisory operations of Australia’s AMP.